Chris has over eight years’ experience supporting and leading medical writing, real-world evidence, market access, and scientific projects across a range of therapeutic areas, including oncology, immunology, neurology, infectious diseases and women’s health.

In addition, Chris has supported HTA submissions and strategy reviews (Nordics/UK) for innovative products in oncology, neurology and rare diseases, and has substantial experience writing scientific publications and conducting targeted and systematic literature reviews.

Having worked across consultancy, industry, and academia in both the UK and Sweden, Chris brings a strong focus on process and quality to every project. He holds a PhD and a MSc from Imperial College London and a BSc in Biological Sciences from the University of Leeds.

Chris previously held postdoctoral research positions at Imperial College London and Stockholm University, where his research focused on molecular biology, antimicrobial resistance, and host–pathogen interactions. He has co-authored more than 15 peer-reviewed scientific publications.

​

Close